Toward elimination of perinatal HIV transmission: New Jersey hospital barriers to rapid HIV testing in labor and delivery, 2005

Public Health Reports

Volumn 126, Issue 1, 2011, Pages 145-152

  Kelley, Carly E ^a,b   Paul, Sindy M ^c   Vali, Firoozeh M ^d   Caruso, Jane M ^e   Martin, Rose M ^g   Fleming, Patricia L ^f  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY   (United States)

^c NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^d New Jersey Hospital Association   (United States)

^e New Jersey Statewide Family Centered HIV Care Network   (United States)

^f RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

AIDS KNOWLEDGE AND ATTITUDES SURVEY; ARTICLE; DELIVERY; FEMALE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABOR; PERINATAL MORBIDITY; PRIORITY JOURNAL; UNITED STATES; VIRUS TRANSMISSION;

EID: 79951536687     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491112600121     Document Type: Article

References (31)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80. (Pubitemid 24331334)
2. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Recomm Rep 1994;43(RR-11):1-20.
3. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep 1995;44(RR-7):1-15.
4. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR Recomm Rep 1998;47(RR-2):1-30.
5. HIV/AIDS surveillance report: cases of HIV infection and AIDS in the United States, 2004 [cited 2009 Feb 22]. Available from: URL: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2004report/pdf/ 2004SurveillanceReport.pdf
6. Bulterys M, Jamieson DJ, O'Sullivan MJ, Cohen MH, Maupin R, Nesheim S, et al. Rapid HIV-1 testing during labor: a multicenter study. JAMA 2004;292:219-23. (Pubitemid 38917999)
7. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet 1999;353:773-80.
8. The PETRA Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (PETRA study): a randomized, double-blind, placebocontrolled trial. Lancet 2002;359:1178-86.
9. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 Kampala, Uganda: HIVNET 012 randomized trial. Lancet 1999;354:795-802. (Pubitemid 29415583)
10. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmissions of HIV-1 Kampala, Uganda: 18 month follow-up of the HIVNET 012 randomized trial. Lancet 2003;362:859-68. (Pubitemid 37130095)
11. Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, et al. A multicenter randomized trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of HIV-1. J Infect Dis 2003;187:725-35. (Pubitemid 36286932)
12. New Jersey Department of Health and Senior Services. Standard of care for women who present in labor with unknown HIV serostatus. January 2002 [cited 2009 Feb 25]. Available from: URL: http://www.state.nj.us/health/aids/stdcare. pdf
13. Paul SM. Rapid diagnostic HIV testing. Presented at the UMDNJ Center for Continuing & Outreach Education; 2005 Nov 3; Princeton, New Jersey.
14. Sia J, Paul S, Martin RM, Cross H. HIV infection and zidovudine use in childbearing women. Pediatrics 2004;114:e707-12.
15. Paul SM, Dimasi L, Cross H, Martin RM, Burr C, Gross E. Reducing vertical HIV transmission in New Jersey. New Jersey AIDSLine, December 2006 [cited 2009 Feb 20]. Available from: URL: http://ccoe.umdnj.edu/catalog/aids/pdf/ AIDSLineDec06.pdf
16. Paul SM, Pollet C, Burr CK, Bardeguez A, Khanlou P. Prevention of perinatal HIV transmission. New Jersey Med 2001;983:23-31.
17. Bogart LM, Howerton D, Lange J, Becker K, Setodji CM, Asch SM. Scope of rapid HIV testing in urban U.S. hospitals. Public Health Rep 2008;123:494-503.
18. Jamieson DJ, Cohen MH, Maupin R, Nesheim S, Danner SP, Lampe MA, et al. Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience. Am J Obstet Gynecol 2007;197(3 Suppl):S72-82.
19. Margolin F, Whitemore H, Stanger K, Pickreign J, Kang R. Preventing perinatal HIV transmission: barriers to universal hospital testing. Poster presented at the Academy Health Annual Research Meeting; 2005 Jun 26; Boston.
20. Vovici Corp. Web Surveyor: Version 3.6. Dulles (VA): Vovici Corp.; 2010.
21. SAS Institute, Inc. SAS®: Version 9.1.3. Cary (NC): SAS Institute, Inc.; 2004.
22. New Jersey Department of Health and Senior Services. New Jersey HIV/AIDS report. June 2008 [cited 2009 Mar 10]. Available from: URL: http://www.state.nj. us/health/aids/documents/qtr608.pdf
23. Bayer R, Fairchild AL. Changing the paradigm for HIV testing - the end of exceptionalism. N Engl J Med 2006;355:647-9.
24. HIV testing among pregnant women - United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep 2002;51(45):1013-6.
25. New Jersey Department of Health and Senior Services. Pregnancy Risk Assessment Monitoring System. Screening for HIV in pregnant women in New Jersey. April 2008 [cited 2009 Mar 10]. Available from: URL: http://www.nj.gov/health/ fhs/professional/documents/brief-hiv-screening.pdf
26. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations of HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55(RR-14):1-17.
27. Henry J. Kaiser Family Foundation. State health facts: HIV testing for mothers and newborns. 2008 [cited 2008 Nov 9]. Available from: URL: http://www.statehealthfacts.org/comparetable.jsp?ind=563&cat=11
28. Henry J. Kaiser Family Foundation. Kaiser daily HIV/AIDS report. New Jersey requires HIV tests for pregnant women, some infants. 2008 Jan 2 [cited 2009 Jan 9]. Available from: URL: http://www.kaisernetwork.org/Daily-reports/ rep-index.cfm?DR-ID=49558
29. Paul SM, Dimasi L. New Jersey's new legislation for HIV testing of pregnant women and newborns. New Jersey AIDSLine, June 2008 [cited 2009 Feb 10]. Available from: URL: http://www.state.nj.us/ health/aids/documents/ aidslinejun08.pdf
30. Cohen MH, Olszewski Y, Webber MP, Blaney N, Garcia P, Maupin R, et al. Women identified with HIV at labor and delivery: testing, disclosing and linking to care challenges. Matern Child Health J 2008;12:568-76.
31. Patterson KB, Leone PA, Fiscus SA, Kuruc J, McCoy SI, Wolf L, et al. Frequent detection of acute HIV infection in pregnant women. AIDS 2007;21:2303-8. (Pubitemid 350287456)